PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27062188-0	2016	Pharmacokinetics of the novel oral prostacyclin receptor agonist selexipag in subjects with hepatic or renal impairment.	selexipag	65-74	prostaglandin I2 receptor	Homo sapiens	35-56	
27062188-1	2016	AIM: The aim of the present study was to explore the effect of hepatic or renal dysfunction on the pharmacokinetics (PK), tolerability and safety of selexipag, an orally active prostacyclin receptor agonist.	selexipag	149-158	prostaglandin I2 receptor	Homo sapiens	177-198